Biologics in Inflammatory Bowel Disease, An issue of Gastroenterology Clinics of North America, E-Book

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Gastroenterology, Ailments & Diseases, Diseases
Cover of the book Biologics in Inflammatory Bowel Disease, An issue of Gastroenterology Clinics of North America, E-Book by Edward V. Loftus, Jr, MD, Elsevier Health Sciences
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Edward V. Loftus, Jr, MD ISBN: 9780323323260
Publisher: Elsevier Health Sciences Publication: August 21, 2014
Imprint: Elsevier Language: English
Author: Edward V. Loftus, Jr, MD
ISBN: 9780323323260
Publisher: Elsevier Health Sciences
Publication: August 21, 2014
Imprint: Elsevier
Language: English

By the time this issue of Gastroenterology Clinics of North America is released, it will have been 16 years since infliximab was approved by the US Food and Drug Administration for the treatment of moderate to severe Crohn disease. Not only have we come a long way in understanding the efficacy and safety of infliximab, we are beginning to understand how and when to use the drug. Furthermore, as of this writing, we have five other biologic agents approved for either Crohn disease or ulcerative colitis, and there are many more molecules currently in drug development for these indications. In this issue,the Editors have assembled a collection of experts to provide the most cutting-edge information on the status of biologic therapy for inflammatory bowel disease.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

By the time this issue of Gastroenterology Clinics of North America is released, it will have been 16 years since infliximab was approved by the US Food and Drug Administration for the treatment of moderate to severe Crohn disease. Not only have we come a long way in understanding the efficacy and safety of infliximab, we are beginning to understand how and when to use the drug. Furthermore, as of this writing, we have five other biologic agents approved for either Crohn disease or ulcerative colitis, and there are many more molecules currently in drug development for these indications. In this issue,the Editors have assembled a collection of experts to provide the most cutting-edge information on the status of biologic therapy for inflammatory bowel disease.

More books from Elsevier Health Sciences

Cover of the book Adolescent Cardiac Issues, An Issue of Pediatric Clinics, E-Book by Edward V. Loftus, Jr, MD
Cover of the book Health Promotion Throughout the Life Span - E-Book by Edward V. Loftus, Jr, MD
Cover of the book Computed Tomography & Magnetic Resonance Imaging Of The Whole Body E-Book by Edward V. Loftus, Jr, MD
Cover of the book Dysphagia E-Book by Edward V. Loftus, Jr, MD
Cover of the book Detoxification by Edward V. Loftus, Jr, MD
Cover of the book Veterinary Dentistry: A Team Approach E-Book by Edward V. Loftus, Jr, MD
Cover of the book Calculating Drug Doses Safely E-Book by Edward V. Loftus, Jr, MD
Cover of the book Basic and Advanced Sciences for Anaesthetic Practice: Prepare for the FRCA by Edward V. Loftus, Jr, MD
Cover of the book Primary Care - E-Book by Edward V. Loftus, Jr, MD
Cover of the book Pediatric Otolaryngology Challenges in Multi-System Disease, An Issue of Otolaryngologic Clinics - E-Book by Edward V. Loftus, Jr, MD
Cover of the book Brain Imaging: Case Review Series E-Book by Edward V. Loftus, Jr, MD
Cover of the book Women's Health by Edward V. Loftus, Jr, MD
Cover of the book Photodermatology, An Issue of Dermatologic Clinics, by Edward V. Loftus, Jr, MD
Cover of the book Testicular Cancer, An Issue of Urologic Clinics, E-Book by Edward V. Loftus, Jr, MD
Cover of the book Language Disorders from Infancy Through Adolescence - E-Book by Edward V. Loftus, Jr, MD
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy